Trial Profile
A study evaluating pattern of changes in therapy for patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Canagliflozin (Primary) ; Dapagliflozin; Empagliflozin; Exenatide; Liraglutide; Saxagliptin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Sep 2017 New trial record
- 15 Sep 2017 Results presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes